Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Cathomen

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Nature Communications|September 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.
Stem Cell Reports|February 15, 2018
Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene InhibitionLaura Ordovás, Ruben Boon, Mariaelena Pistoni, et al.
Stem Cell Reports|October 13, 2015
Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene InhibitionLaura Ordovás, Ruben Boon, Mariaelena Pistoni, et al.
Cell Stem Cell|May 14, 2026
Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammationLei Lei, Masako M Kaufmann, Jessica Lao, et al.
Cell Reports. Medicine|June 19, 2024
Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseasesFederica Esposito, Fabio Dell'Aquila, Manuel Rhiel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activityFranziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2022
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosaJohannes Bischof, Oliver Patrick March, Bernadette Liemberger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosaMarkus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Nature Communications|May 27, 2024
Deciphering bat influenza H18N11 infection dynamics in male Jamaican fruit bats on a single-cell levelSusanne Kessler, Bradly Burke, Geoffroy Andrieux, et al.
Biorxiv : the Preprint Server for Biology|December 20, 2023
Integration of ζ-deficient CARs into the <i>CD3-zeta</i> gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Nature Communications|September 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.
Stem Cell Reports|February 15, 2018
Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene InhibitionLaura Ordovás, Ruben Boon, Mariaelena Pistoni, et al.
Stem Cell Reports|October 13, 2015
Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene InhibitionLaura Ordovás, Ruben Boon, Mariaelena Pistoni, et al.
Cell Stem Cell|May 14, 2026
Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammationLei Lei, Masako M Kaufmann, Jessica Lao, et al.
Cell Reports. Medicine|June 19, 2024
Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseasesFederica Esposito, Fabio Dell'Aquila, Manuel Rhiel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activityFranziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2022
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosaJohannes Bischof, Oliver Patrick March, Bernadette Liemberger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosaMarkus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Nature Communications|May 27, 2024
Deciphering bat influenza H18N11 infection dynamics in male Jamaican fruit bats on a single-cell levelSusanne Kessler, Bradly Burke, Geoffroy Andrieux, et al.
Biorxiv : the Preprint Server for Biology|December 20, 2023
Integration of ζ-deficient CARs into the <i>CD3-zeta</i> gene conveys potent cytotoxicity in T and NK cellsJonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Pageof 18